Acute Myeloid Leukemia (AML) is a type of cancer that impacts the blood and bone marrow, characterized by the rapid growth of abnormal white blood cells. Among the genetic factors contributing to AML, the ETO t(8;21) gene rearrangement stands out due to its significant implications on diagnosis, treatment, and prognosis. DNA Labs UAE offers a cutting-edge PCR Qualitative Test specifically designed to detect the AML ETO t(8;21) gene rearrangement, providing critical information for healthcare providers and patients. This article delves into the symptoms associated with AML, the importance of the AML ETO t(8;21) gene rearrangement PCR Qualitative Test, and its cost.
Symptoms of Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia can manifest a range of symptoms, often subtle at first but becoming more pronounced as the disease progresses. Early detection and diagnosis are crucial for effective treatment. Common symptoms include:
- Fatigue and weakness, due to anemia
- Fever and infections, as a result of neutropenia
- Bruising or bleeding easily, caused by a reduction in platelet count
- Shortness of breath during physical activity
- Weight loss or loss of appetite
- Bone or joint pain
- Enlarged spleen or liver, detected in physical exams
The Importance of AML ETO t(8;21) Gene Rearrangement PCR Qualitative Test
The AML ETO t(8;21) gene rearrangement is a specific genetic abnormality found in a subset of AML patients. This rearrangement involves the translocation between chromosomes 8 and 21, resulting in a fusion gene that contributes to the development of leukemia. Detecting this rearrangement is critical for diagnosing certain subtypes of AML, guiding treatment decisions, and assessing prognosis. The PCR Qualitative Test offered by DNA Labs UAE utilizes advanced molecular techniques to accurately identify the presence of the AML ETO t(8;21) gene rearrangement, providing valuable insights into the disease.
Test Cost and Accessibility
The AML ETO t(8;21) Gene Rearrangement PCR Qualitative Test is priced at 1000 AED. This cost reflects the sophisticated technology and expertise required to perform the test and analyze the results. Patients and healthcare providers can access detailed information and request the test by visiting DNA Labs UAE. The website provides comprehensive details about the test, including preparation, procedure, and interpretation of results.
Conclusion
Acute Myeloid Leukemia is a complex disease, with genetic factors like the AML ETO t(8;21) gene rearrangement playing a crucial role in its development and progression. Recognizing the symptoms of AML and undergoing timely testing can significantly impact the outcome. The AML ETO t(8;21) Gene Rearrangement PCR Qualitative Test offered by DNA Labs UAE is a vital tool in the fight against AML, providing essential information for the diagnosis and management of the disease. With a cost of 1000 AED, this test is an investment in health, offering hope and direction for patients and their families.
